Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
申请人:Pfizer Inc.
公开号:US06262046B1
公开(公告)日:2001-07-17
Compounds of the formula (I):
where X1, A, Ar1, X and R are as defined in the specification, and pharmaceutically-acceptable salts thereof, are new, and are useful as tachykinin inhibitors which act at the NK1, NK2 and NK3 receptors or a combination of two or more thereof.
化合物的结构式(I):其中X1、A、Ar1、X和R如规范中定义,并且其药学上可接受的盐是新的,并且可用作在NK1、NK2和NK3受体上起作用的催吐肽拮抗剂或两种或更多种的组合。